
|Articles|November 10, 2007
New pharmaceutical products for glaucoma in the pipeline
The drug development pipeline is bursting with new pharmaceutical products that may one day be useful in glaucoma therapy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Port Delivery System Therapies in Retinal Vascular Diseases
4
Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye
5






















